Amycretin shows 22% weight loss in early trials

[eggrollfever]

New oral GLP-1 drug developed by Novo Nordisk outperformed any others so far in an early trial with results released today. Will be interesting to see how long it takes to hit the UGL market.

 

[sushak]

New oral GLP-1 drug developed by Novo Nordisk outperformed any others so far in an early trial with results released today. Will be interesting to see how long it takes to hit the UGL market.

Wasn't oral, the results were based on subq administration. Cool nonetheless!

 

[noteablequotable]

New oral GLP-1 drug developed by Novo Nordisk outperformed any others so far in an early trial with results released today. Will be interesting to see how long it takes to hit the UGL market.

Was waiting for this news. My Novo calls are finally starting to recover, lol

 

[AlexDavis43]

Wasn't oral, the results were based on subq administration. Cool nonetheless!

They also make an oral version, similarly impressive weight loss (ref)

 

[sushak]

They also make an oral version, similarly impressive weight loss (ref)

Thanks, the press release I read about the cause of the stock gain today suggested it was the subq trial

 

[glpfun]

NA-931 is the one to keep an eye on

 

[Yosyrj]

When are the Chinese starting to get their hands on this ?
I don't see any